Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease - Top-Institutions - MDSpire

Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease

  • By

  • Cyril Brzenczek

  • Quentin Klopfenstein

  • Tom Hähnel

  • Stefano Sapienza

  • Jochen Klucken

  • Holger Fröhlich

  • Enrico Glaab

  • November 7, 2025

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Luxembourg Centre for Systems Biomedicine, University of Luxembourg
    Luxembourg Centre for Systems Biomedicine, University of Luxembourg

    Esch-sur-Alzette, Luxembourg

    Key Differentiators

    • Systems Biomedicine
    • Neurology
    • Bioinformatics
    • Digital Biomarkers

  • #2

    Luxembourg Institute of Health
    Luxembourg Institute of Health

    Strassen, Luxembourg

    Key Differentiators

    • Clinical Research
    • Metabolomics
    • Neurology

  • #3

    TUD Dresden University of Technology, Medical Faculty and University Hospital Carl Gustav Carus
    TUD Dresden University of Technology, Medical Faculty and University Hospital Carl Gustav Carus

    Dresden, Saxony

    Key Differentiators

    • Neurology
    • Clinical Neurophysiology
    • Digital Health

  • #4

    Fraunhofer Institute for Algorithms and Scientific Computing
    Fraunhofer Institute for Algorithms and Scientific Computing

    Sankt Augustin, North Rhine-Westphalia

    Key Differentiators

    • Bioinformatics
    • Algorithm Development
    • Digital Medicine

Original Source(s)

Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease

  • by Cyril Brzenczek, Quentin Klopfenstein, Tom Hähnel, Stefano Sapienza, Jochen Klucken, Holger Fröhlich, Enrico Glaab

  • November 7, 2025

Related Content

ARPA-H Launches New Program to Deliver Rigorous, Gold-Standard Research Faster

Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

Japan Clears First iPSC Therapies for Clinical Use 

Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials

  • March 25, 2026

  • 2 min